FDA Notice to Pharmaceutical Firm for Using Imported Sweeteners

After the seizure of chemicals worth Rs 42 lakh from a chemical company in Bhiwandi last week, the Food and Drugs Administration (FDA) of Maharashtra has now sent a notice to a major pharmaceutical company for using imported food sweeteners in medicines without license.
According to information from the FDA, the pharma company, located in Bhiwandi was illegally selling ‘Lactitol Monohydrate’ chemical from China to many pharmaceutical companies. “After receiving a tip off about illegal imports, raid was conducted at the premises of the Bhiwandi company and found that it was importing the chemical as an ingredient for food products, but selling it to pharmaceutical companies for use in medicines,” said official.
A senior official of FDA said that selling the chemicals without license is illegal under provisions of the Drugs and Cosmetics Act 1940. “During the raid 12,730 kg of Lactitol Monohydrate worth Rs 42 lakh was seized,” added official.
Dr. Harshdeep Kamble, FDA commissioner said that the company had also given an undertaking to the Central Drugs Standard Control Organization (CDSCO) saying that the material would not be used or sold for medicinal purposes.
"During the investigation it was revealed that the company had given an undertaking to the Central government saying that they would import the drugs but not for medicinal use. But the company imported the chemical from a Chinese company and sold it to different pharmaceutical companies so that it will be used in medicines," added Dr. Kamble.
Dr. Kamble further stated that the notices has been issued to the pharmaceutical companies and asked them to give the complete details about the products. “The samples which have been seized are sent to the laboratories for analysis,” added Dr.Kamble.
Looking for chemical products? Let suppliers reach out to you!
2026-06-03
-
Life Science Ingredients Industry Overview
This issue offers a deep exploration of the evolving pharmaceutical and nutrition landscape, combining data, analysis, and insight to reveal key industry shifts and emerging directions. Support online permanent download.Published in: Nov. 2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA delays proposal to ban formaldehyde in hair straighteners
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
-
FDA Releases New Resources for Food Traceability Final Rule Compliance
-
IFSAC Unveils 2021 Report: Diverse Food Sources Linked to Salmonellosis Cases
-
FDA to Nationwide Ban Brominated Vegetable Oil (BVO) in Food
-
FDA Issues Warning to Produce Importer for Non-Compliance
-
FDA Proposes Ban on Hair Relaxers Containing Formaldehyde
-
US FDA Issues Alert: High Lead Levels Detected in Baby Fruit Puree
-
Yehui Pharmaceuticals' BN104 Receives Fast Track Designation from FDA for the Treatment of Relapsed/Refractory Acute Leukemia
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
Recommend Reading
-
New Medicines Restore Heart Function in 25 Percent of Heart Failure Patients
-
Indian CRDMOs See Growth as Global Pharma Diversifies Operations
-
US Senator Investigates GSK's Removal of Asthma Inhaler Amid Crisis
-
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
IMCD Acquires Chilean Specialty Chemicals Distributor
-
Europe’s Chemical Industry in the Ice Age: Profits Evaporating, Plants Shutting Down, Capital Fleeing—A Systemic Collapse Is Underway
-
After Hitting Bottom in 2025, Melamine Strongly Rebounds in China; Can 2026 See a Demand-Driven Turnaround?
-
Arkema Triples Transparent Polyamide Capacity in Singapore: a Bet on Virtual Reality Growth or a Move to Strengthen Supply Resilience?
-
This week, the caustic soda price was weak (10.27-10.30) in China